Prof. Hermann Mascher

Founder and Bioanalytical Consultant

Hermann Mascher is the founder and former CEO of pharm-analyt. A chemist and analyst, he has made a name for himself in the course of the past 45 years in the fields of bioanalytics, metabolism and pharmacokinetics.

He will continue his employment at pharm-analyt as Bioanalytical Consultant with a focus on biomarkers and new approaches in assay development.

Most of his scientific papers have been published in peer-reviewed journals.

First awarded a “Who’s Who in the World” listing over 20 years ago, he is the recipient of a number of innovation and science prizes.

Hand-in-hand with the company’s specialist scientific focus, the Management Team at pharm-analyt is also conscious of an ethical obligation in the world at large, derived from a deeply held faith in Jesus Christ. This is why it supports several programmes aimed at improving people’s living conditions in both material, social and psychological terms – especially, although not only, for children and young people.

pharm-analyt believes that today’s world offers no shortage of opportunities for people to get involved in improving the lives of others, both as citizens and as Christians.

Dr. Daniel Mascher

Chief Operating Officer (COO)

Together with the study directors, he is the point of contact for sponsors during the implementation of their studies.
Daniel Mascher is a physicist, whose doctoral thesis was in the field of bioanalytics, on HPLC mass spectrometry of trace-level organic molecules.

This area of knowledge – greatly extended at pharm-analyt over many years as GLP/GMP/GCP-study director – is one which he brings to bear very effectively as the COO, facilitating an efficient mode of working among our in-house study directors. He heads a youthful team of analysts and covers both test facility management (GLP) and control laboratory management (GMP).

For GMP studies 2 Qualified Persons (QP), Dr. Klaus Kubesch and Mag. Christian Kikuta, support him.

MMag. Klaus Mascher

Chief Executive Officer (CEO)

With a business administration background and after two years in documentation at pharm-analyt Klaus took over as CEO in 2017. In 2020 he experienced his most challenging year as a CEO building on his logistics major in order to implement new rules and procedures to get through the pandemic.

Dipl.-Ing. Elisabeth Feik

Head of Documentation and COO by proxy

Elisabeth joined pharm-analyt in 2015 and became a valuable member of the team. Her focus on quality on many levels has led to more solid and understandable documents that go out to clients. With her social competence also the team spirit has increased.

Felix Joussein

Head of IT

Felix joined pharm-analyt in 2016, some months later he became head of IT. By combining the best of the pharm-analyt history and his 20 years of experience in IT pharm-analyt with its “PA2020” is now aiming at “PA2025” as next IT vision. As an example now a CEPH architecture with full reliance on SSDs is at the core of the pharm-analyt's network. His personal credo "Do it right the first time" is a guideline for his work.